Ins(1,4,5)P3 and cardiac dysfunction

Cardiovascular Research

Volumn 40, Issue 2, 1998, Pages 251-256

  Woodcock, Elizabeth A ^a   Matkovich, Scot J ^a   Binah, Ofer ^b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Arrhythmia (mechanisms); Calcium (cellular); Immunology; Reperfusion; Signal transduction

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; INOSITOL 1,4,5 TRISPHOSPHATE; PHOSPHOLIPASE C; PROTEIN TYROSINE KINASE;

APOPTOSIS; CALCIUM CELL LEVEL; CHAGAS DISEASE; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; ARRHYTHMIA; CALCIUM; HEART FAILURE, CONGESTIVE; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; MODELS, CARDIOVASCULAR; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; SIGNAL TRANSDUCTION;

EID: 0032212664     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00187-4     Document Type: Review

References (68)

1. [1] Berridge MJ. Inositol triphosphate and diacylglycerol: two interacting second messengers. Ann Rev Biochem 1987;56:159-193.
2. [2] Berridge MJ, Dupont G. Spatial and temporal signalling by calcium. Curr Opin Cell Biol 1994;6:267-274.
3. [3] Berridge MJ. Elementary and global aspects of calcium signalling - Annual Review Prize Lecture. J Physiol (London) 1997;499:291-306.
4. [4] Berridge M. The AM and FM of calcium signalling. Nature 1997;286:759-760.
5. 3. Am J Physiol 1990;258:H610-H615.
6. 2+ release from cardiac sarcoplasmic reticulum. Pflugers Arch 1991;418:1-6.
7. [7] Kass RS, Lederer WJ, Tsien RW, Weingart R. Role of calcium ions in transient inward currents and aftercontractions induced by strophanthidin in cardiac Purkinje fibers. J Physiol (London) 1978;281:187-208.
8. [8] Lederer WJ, Tsien RW. Transient inward current underlying arrhythmogenic effects of cardiotonic steroids in Purkinje fibers. J Physiol (London) 1976;263:73-100.
9. [9] Kleber A, Fast V. Molecular and cellular aspects of re-entrant arrhythmias. Basic Res Cardiol 1997;92(Suppl. 1):111-119.
10. [10] de Mello WC. Effect of intracellular injection of calcium and strontium in cell communication in heart. J Physiol (London) 1975;250:231-245.
11. [11] de Mello WC. Cell-to-cell communication in heart and other tissues. Prog Biophys Mol Biol 1982;39:147-182.
12. 2+. Am J Physiol 1987;253:C607-C612.
13. ++ . J Gen Physiol 1990;95:1061-1075.
14. [14] Gilbert JC, Shirayama T, Pappano AJ. Inositol trisphosphate promotes Na-Ca exchange current by releasing calcium from sarcoplasmic reticulum in cardiac myocytes. Circ Res 1991;69:1632-1639.
15. [15] Orrenius S, Nicotera P. The calcium ion and cell death. J Neural Transm 1994;43:1-11.
16. 2+-mediated endonuclease activation. Science 1988;242:256-259.
17. [17] Khan AA, Soloski MJ, Sharp AH, et al. Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor. Science 1996;273:503-507.
18. [18] Marks A. Intracellular calcium-release channels: regulators of cell life and death. Am J Physiol 1997;272:H597-H605.
19. [19] Jayaraman T, Marks AR. T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis. Mol Cell Biol 1997;17:3005-3012.
20. [20] Pulkki KJ. Cytokines and cardiomyocyte death. Ann Med 1997;29:339-343.
21. [21] MacLellan WR, Schneider MD. Death by design - programmed cell death in cardiovascular biology and disease. Circ Res 1997;81:137-144.
22. [22] Park DS, Stefanis L, Greene LA. Ordering the multiple pathways of apoptosis. Trend Cardiovasc Med 1997;7:294-301.
23. [23] Eischen CM, Leibson PJ. The Fas pathway in apoptosis. Adv Pharmacol 1997;41:107-132.
24. [24] Barry W Mechanisms of immune-mediated myocyte injury. Circulation 1994;89:2421-2432.
25. [25] Binah O. Immune effector mechanisms in heart transplant rejection. Cardiovasc Res 1994;28:1748-1757.
26. 3 cascade in the damage to guinea-pig ventricular myocytes induced by cytotoxic T lymphocytes. Pflugers Arch 1997;433:721-726.
27. [27] Berke G. The Fas-based mechanism of lymphocytotoxicity. Hum Immunol 1997;54:1-7.
28. [28] Berridge MJ. Lymphocyte activation in health and disease. Crit Rev Immunol 1997;17:155-178.
29. [29] Felzen B, Shilkrut M, Less H, et al. Fas (CD95/Apo-1)-mediated damage to ventricular myocytes induced by cytotoxic T lymphocytes from perform gene-knockout mice: involvement of inositol trisphosphate. Circ Res 1998;82:438-450.
30. 2+ concentrations in guinea pig heart. Jpn Circ J 1993;57:344-353.
31. [31] He H, Lam M, McCormick TS, Distelhorst CW. Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl-2. J Cell Biol 1997;138:1219-1228.
32. 2+ stores in induction and suppression of apoptosis in S49 cells. Am J Physiol 1997;272:C1241-1249.
33. [33] Gorza L, Schiaffino S, Volpe P. Inositol 1,4,5-trisphosphate receptor in heart - evidence for its concentration in Purkinje myocytes of the conduction system. J Cell Biol 1993;121:345-353.
34. [34] Kijima Y, Saito A, Jetton TL, Magnuson MA, Fleischer S. Different intracellular localization of inositol 1,4,5-trisphosphate and ryanodine receptors in cardiomyocytes. J Biol Chem 1993;268:3499-3506.
35. [35] Ferez PJ, Ramos-Franco J, Fill M, Mignery GA. Identification and functional reconstitution of the type 2 inositol 1,4,5-trisphosphate receptor from ventricular cardiac myocytes. J Biol Chem 1997;272:23961-23969.
36. [36] Moretta A. Molecular mechanisms in cell-mediated cytotoxicity. Cell 1997;90:13-18.
37. [37] Balajthy Z, Kedei N, Nagy L, Davies PJA, Fesus L. Lack of induction of tissue transglutaminase but activation of the preexisting enzyme in c-Myc-induced apoptosis of CHO cells. Biochem Biophys Res Commun 1997;236:280-284.
38. [38] Toyoshima F, Moriguchi T, Nishida E. Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-038 pathways independent of CPP32-like proteases. J Cell Biol 1997;139:1005-1014.
39. [39] Gulbins E, Brenner B, Koppenhoefer U, Linderkamp O, Lang F. Fas or ceramide induce apoptosis by Ras-regulated phosphoinositide-3-kinase activation. J Leukocyte Biol 1998;63:253-263.
40. [40] Sheridan DJ. Alpha adrenoceptors and arrhythmias. J Mol Cell Cardiol 1986;18:59-68.
41. [41] Kinoshita K, Hearse D, Braimbridge M, Manning A. Ischemia- and reperfusion-induced arrhythmias in conscious rats. Jpn Circ J 1988;52:1384-1392.
42. [42] Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994;94:1621-1628.
43. 1-adrenergic system and arrhythmias in ischaemic heart disease. Eur Heart J 1991;12:88-98.
44. [44] Goldstein J, Michelle M, Butterfield C, et al. Arrhythmogenic influence of intracoronary thrombosis during acute myocardial ischemia. Circulation 1994;90:139-147.
45. [45] Jacobsen AN, Du XJ, Lambert KA, Dart AM, Woodcock EA. Arrhythmogenic action of thrombin during myocardial reperfusion via release of inositol 1,4,5-triphosphate. Circulation 1996;93:23-26.
46. [46] Anderson K, Dart A, Woodcock E. Inositol phosphate release and metabolism during myocardial ischemia and reperfusion in rat heart. Circ Res 1995;76:261-268.
47. 3 release. Circulation 1995;91:2712-2716.
48. [48] Salmon A, Mays J, Dalton G, Jones J, Levi A. Effect of streptomycin on wall-stress-induced arrhythmias in working rat heart. Cardiovasc Res 1997;34:493-503.
49. [49] Dassouli A, Sulpice JC, Roux S, Crozatier B. Stretch-induced inositol trisphosphate and tetrakisphosphate production in rat cardiomyocytes. J Mol Cell Cardiol 1993;25:973-982.
50. [50] von Harsdorf R, Lang R, Fullerton M, Smith A, Woodcock E. Right atrial dilatation increases inositol-(1,4,5)trisphosphate accumulation: implications for the control of atrial natriuretic peptide secretion. FEBS Lett 1988;233:201-215.
51. [51] von Harsdorf R, Lang R, Fullerton M, Woodcock EA. Myocardial stretch stimulates phosphatidylinositol turnover. Circ Res 1989;65:494-501.
52. [52] Paul K, Ball N, Dorn G, Walsh R. Left ventricular stretch stimulates angiotensin II-mediated phosphatidylinositol hydrolysis and protein kinase C∈ isoform translocation in adult guinea pig hearts. Circ Res 1997;81:643-650.
53. [53] Piot CA, Padmanaban D, Ursell PC, Sievers RE, Wolfe CL. Ischemic preconditioning decreases apoptosis in rat hearts in vivo. Circulation 1997;96:1598-1604.
54. [54] Piot C, Wolfe C. Apoptosis: a new mechanism of lethal myocyte reperfusion injury? J Throm Thrombol 1997;4:67-68.
55. [55] Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86-107.
56. [56] Tanaka M, Ito H, Akimoto S, et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994;75:426-433.
57. [57] Birdsall H, Green D, Trial J, et al. Complement C5a, TGF-b1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. Circulation 1997;95:684-692.
58. [58] Sharma HS, Das DK. Role of cytokines in myocardial ischemia and reperfusion. Mediators Inflamm 1997;6:175-183.
59. [59] Limas C. Cardiac autoantibodies in dilated cardiomyopathy. Circulation 1997;95:1979-1980.
60. [60] Pogwizd SM. Nonreentrant mechanisms underlie spontaneously occurring ventricular arrhythmias in dilated cardiomyopathy (Abstract). Circulation 1993;88:I326.
61. [61] Pogwizd SM, Hoyt RH, Saffitz JE, et al. Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation 1992;86:1872-1887.
62. [62] Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. New Engl J Med 1996;335:1182-1196.
63. [63] Brodde OE, Michel MC, Zerkowski HR. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovasc Res 1995;30:570-584.
64. [64] Beinlich CJ, Morgan HE. Control of growth in neonatal pig hearts. Mol Cell Biochem 1993;119:3-9.
65. [65] Knowlton KU, Michel MC, Itani M, et al. The alpha-1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem 1993;268:15374-15380.
66. [66] Milano CA, Dolber PC, Rockman HA, et al. Myocardial expression of a constitutively active alpha(1B)-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA 1994;91:10109-10113.
67. [67] D'Angelo D, Sakata Y, Lorenz J, et al. Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA 1997;94:8121-8126.
68. [68] Go LO, Moschella MC, Watras J, et al. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest 1995;95:888-894.